Cargando…

Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma

PURPOSE: Radiation-associated angiosarcoma (RAAS) is a rare complication among patients treated with radiation therapy for breast cancer. Hyperfractionated-accelerated reirradiation (HART) improves local control after surgery. Proton therapy may further improve the therapeutic ratio by mitigating po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Looi, Wen Shen, Bradley, Julie A., Liang, Xiaoying, Shaw, Christiana M., Leyngold, Mark, Mailhot Vega, Raymond B., Brooks, Eric D., Rutenberg, Michael S., Spiguel, Lisa R., Giap, Fantine, Mendenhall, Nancy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009453/ https://www.ncbi.nlm.nih.gov/pubmed/35530187 http://dx.doi.org/10.14338/IJPT-21-00031.1

Ejemplares similares

Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
por: Moningi, Shalini, et al.
Publicado: (2019)

Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
por: Hunt, Andrew, et al.
Publicado: (2018)

Intraoperative radiation therapy for early-stage breast cancer: a single-institution experience
por: Giap, Fantine, et al.
Publicado: (2022)

Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018)

Concomitant Radiation Recall Dermatitis and Organizing Pneumonia following Breast Radiotherapy: A Case Report
por: Liu, I-Chia, et al.
Publicado: (2020)

Proton Therapy for Bilateral Breast Cancer Maximizes Normal-Tissue Sparing
por: Brooks, Eric D., et al.
Publicado: (2023)

Racial and Ethnic Demographic Reporting in Phase 2 Proton Therapy Clinical Trials: A Review
por: Fakhry, Jonathan S., et al.
Publicado: (2023)

Intensification of Treatment for Angiosarcoma of the Breast with Accelerated Hyperfractionated Radiation, Hyperthermia, and Surgical Resection
por: Molitoris, Jason K, et al.
Publicado: (2017)

Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer
por: Liang, Xiaoying, et al.
Publicado: (2020)

RBE‐weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy
por: Liu, Chunbo, et al.
Publicado: (2022)

Incidence of Rib Fracture following Treatment with Proton Therapy for Breast Cancer
por: Bradley, Julie A., et al.
Publicado: (2023)

A comprehensive dosimetric study of Monte Carlo and pencil‐beam algorithms on intensity‐modulated proton therapy for breast cancer
por: Liang, Xiaoying, et al.
Publicado: (2018)

Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer
por: Liang, Xiaoying, et al.
Publicado: (2018)

Continuous, hyperfractionated, accelerated radiotherapy (CHART).
por: Dische, S., et al.
Publicado: (1989)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
por: Way, Ashley, et al.
Publicado: (2021)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration
por: Baron, Jonathan A., et al.
Publicado: (2022)

Preoperative Accelerated Hyperfractionated Whole-Breast Radiation as Treatment for Secondary Angiosarcoma of the Breast After Prior Accelerated Hypofractionated Whole-Breast Radiation Therapy: A Case Report and Review of the Literature
por: Layton, Christina, et al.
Publicado: (2022)

Clinical Outcomes of Intensity Modulated Proton Therapy Reirradiation for Gynecologic Malignancies
por: Pollock, Ariel E., et al.
Publicado: (2023)

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)

Reirradiation for recurrent craniopharyngioma
por: Foran, Sarah J., et al.
Publicado: (2020)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma
por: Lee, Anna, et al.
Publicado: (2023)

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
por: Bates, James E., et al.
Publicado: (2021)

Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
por: Takeda, Kazuya, et al.
Publicado: (2021)

Reirradiation to the abdomen for gastrointestinal malignancies
por: Haque, Waqar, et al.
Publicado: (2009)

Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials
por: Liu, Yingyu, et al.
Publicado: (2017)

Outcome of cerebral arteriovenous malformations after linear accelerator reirradiation
por: Moraes, Paulo L., et al.
Publicado: (2015)

Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancer
por: Tamaki, Yukihisa, et al.
Publicado: (2015)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Reirradiation of recurrent breast cancer with proton beam therapy: A case report and literature review
por: Lin, Yi-Lan
Publicado: (2019)

Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
por: Wick, Wolfgang, et al.
Publicado: (2019)

RONC-24. PROTON THERAPY FOR PEDIATRIC EPENDYMOMA: MATURE OUTCOMES FROM THE UNIVERSITY OF FLORIDA AND MASSACHUSETTS GENERAL HOSPITAL
por: Indelicato, Daniel J, et al.
Publicado: (2020)

Reirradiation for Rectal Cancer Using Pencil Beam Scanning Proton Therapy: A Single Institutional Experience
por: Koroulakis, Antony, et al.
Publicado: (2020)

RONC-22. SECOND TUMORS IN PEDIATRIC PATIENTS TREATED WITH PROTON THERAPY TO THE CENTRAL NERVOUS SYSTEM
por: Indelicato, Daniel J, et al.
Publicado: (2020)

Current status and recent advances in reirradiation of glioblastoma
por: Minniti, Giuseppe, et al.
Publicado: (2021)

Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry
por: Saeed, Ali M., et al.
Publicado: (2020)

Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
por: Eakin, R. L., et al.
Publicado: (2000)

Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer
por: Doi, Hiroshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l7uun4o98u0lttlj38o5b9bt0o